SpotItEarly
At-Home Cancer Test for Breast, Colorectal, Lung & Prostate
Englewood, United States · $26.5M raised
- Headquarters
- Englewood, New Jersey
- Business Model
- B2C
- Website
- spotitearly.com
- Total Funding
- $26.5M
- Last Round
- $20.3M Series AMay 2025
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.
About
SpotitEarly offers at-home cancer pre-screening with an AI-based breath test that detects multiple cancer types including breast, lung, colorectal, and prostate.
Summary
SpotItEarly is an Artificial Intelligence company based in Englewood, United States. It has raised $26.5M in total across 2 rounds, most recently a $20.3M Series A round in May 2025. Investors include Hanaco Ventures.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2025
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/spotitearly"><img src="https://indexed.vc/api/badge/company/spotitearly" alt="SpotItEarly on Indexed.vc" width="260" height="76" /></a>